FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to piperidine derivatives listed in the patent claim and having the property to intensify glucocerebrosidase activity, a based pharmaceutical composition, method of treating using them, and kit for treating Parkinson's disease.
EFFECT: producing the new compositions.
16 cl, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| NEW COMPOSITIONS FOR PREVENTING AND/OR TREATING LYSOSOMAL STORAGE DISEASES | 2010 |
|
RU2608520C2 |
| RMT5 INHIBITORS | 2019 |
|
RU2814198C2 |
| SECONDARY MANNOSIS FOR BACTERIAL INFECTIONS TREATMENT | 2013 |
|
RU2667060C2 |
| COMPOUNDS - SULFAMATE DERIVATIVES FOR USE IN TREATING OR RELIEVING PAIN | 2014 |
|
RU2699025C1 |
| COMPOUNDS AND COMPOSITIONS USED FOR TREATMENT OF NTRK-RELATED DISORDERS | 2016 |
|
RU2744974C2 |
| METHOD OF TREATMENT OF DISEASES AT MAMMALS | 2004 |
|
RU2344121C2 |
| COMPOSITIONS COMPRISING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2 AND METHODS OF USING THEREOF | 2012 |
|
RU2669921C2 |
| SUBSTITUTED PURINE AND 7-DEAZAPURINE COMPOUNDS | 2011 |
|
RU2606514C2 |
| CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DESTRUCTION OF ANDROGEN RECEPTORS AND USE THEREOF | 2020 |
|
RU2825000C2 |
| TLR7 AGONISTS | 2019 |
|
RU2817014C2 |
